Novotech partners with Asian Eye Institute to accelerate clinical trials

Sydney-based contract research organisation Novotech has partnered with the Asian Eye Institute (AEI), a private eye centre in the Philippines, to facilitate rapid feasibility, start-up and recruitment processes for its ophthalmology clients.

Novotech works in partnership with leading medical institutions across Asia to accelerate quality clinical research. The AEI is one such institution, having conducted over 100 clinical trials and become one of the leading sites in Asia for research into ophthalmic drugs and devices.

The new partnership is designed to give Novotech clients faster start-up times, and access to the AEI patient database and leading principal investigators. Under the terms of a memorandum of understanding, the AEI will provide its professional and clinical trial expertise to Novotech-managed studies including feasibility, principal investigator selection, patient recruitment and execution of ophthalmology studies.

Dr Yooni Kim, Novotech Executive Director, Asia Operations, said the Philippines is well established as a premier clinical research location.

“The MOU means Novotech will also have dedicated clinical experts within the AEI to support and prioritise rapid clinical processes for Novotech biopharma clients,” Dr Kim said.

Novotech describes itself as one of the Asia–Pacific’s leading clinical trial companies, and so is committed to establishing ongoing engagement with leading medical institutions in each country across the region. According to Dr Kim, “We have offices and teams on the ground as well as MOUs and long-term relationships with major hospitals that directly benefit our clients.

“Our in-country relationships enable a more comprehensive understanding of local regulatory changes, access to leading PIs, strong site connections and productive patient populations to deliver success for our clients within timelines and budgets,” she said.

Image caption: Benjamin K Liboro, President of Asian Eye Institute, and Dr Yooni Kim, Executive Director, Asia Operations Novotech.